--- title: "Mid-2026 Disparate Tech and Financials Roundup: Fannie Mae Posts 4B Net, Microcaps Pivot" type: "News" locale: "en" url: "https://longbridge.com/en/news/296207387.md" description: "An eclectic mix of US equities and funds reported diverging financial and strategic outcomes in mid-2026. Fannie Mae delivered a strong Q2 profit, while smaller entities actively navigated capital raises and business shifts." datetime: "2026-08-18T09:44:13.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/296207387.md) - [en](https://longbridge.com/en/news/296207387.md) - [zh-HK](https://longbridge.com/zh-HK/news/296207387.md) --- # Mid-2026 Disparate Tech and Financials Roundup: Fannie Mae Posts 4B Net, Microcaps Pivot An eclectic mix of US equities and funds is reporting diverging financial and strategic outcomes in mid-2026, according to recent company filings and market data. While large-cap financial entities are posting robust profitability, several microcap firms are accelerating their capital operations to navigate strategic shifts and regulatory hurdles. ### Fannie Mae (FNMA.US) The government-sponsored enterprise reported solid financial results for the second quarter of 2026. Fannie Mae achieved a net income of **USD 4 billion**, up 7% from the previous quarter, with net revenues growing to **USD 7.6 billion**. According to a stress test report released on August 14, the firm demonstrated significant resilience under hypothetical severely adverse economic scenarios. ### Optical Cable Corporation (OCC.US) The fiber optic manufacturer is seeing a clear expansion in its business metrics. For its fiscal Q2 2026, OCC's net sales jumped 26.6% year-over-year to **USD 22.2 million**, swinging to a net income of **USD 1.1 million**. The company's sales order backlog increased to **USD 13.3 million** by the end of the quarter. In addition, the firm was added to the Russell Microcap Index on June 29, 2026, potentially boosting its visibility among institutional investors. ### POET Technologies (POAS.US) POET logged Q2 2026 revenue of **USD 569,925**, representing a 112% year-over-year increase and marking its sixth consecutive quarter of sequential growth. Net loss narrowed to **USD 11.3 million**. The company successfully completed a **USD 400 million** financing round in May, securing substantial capital for its photonics solutions, despite the cancellation of certain purchase orders by a major client earlier in April. ### Apollomics (APLM.US) The clinical-stage biopharmaceutical firm recently executed a series of capital market maneuvers. According to an August 11 announcement, Apollomics completed a **USD 10 million** private placement transaction, supported by executive purchases. This follows a July 13 update where the company confirmed it had fully regained compliance with Nasdaq listing requirements. ### Windtree Therapeutics (WINT.US) Windtree is navigating a complex business transition. The company announced a delay in filing its annual report in April 2026. After signing a letter of intent in late 2025 to acquire a fintech firm to diversify its operations, the company is still advancing its core cardiovascular clinical trials while dealing with ongoing operational restructuring. ### Sector Landscape Against a backdrop of fluctuating macro interest rates, fixed-income tracking vehicles faced mild headwinds, with the Vanguard Intermediate-Term Bond Index Fund (**VBIL.US**) recording a year-to-date return of **down 0.67%** as of mid-August 2026. Meanwhile, specific catalysts remain largely absent for other entities in this broader group, including the iShares MSCI Turkey ETF (**TUR.US**), Subversive Capital Advisor ETF (**OPPJ.US**), Incyte (**INCY.US**), and enCore Energy (**EU.US**), all of which have seen relatively quiet capital flows in recent weeks. _This article does not constitute investment advice._ ### Related Stocks - [INCY.US](https://longbridge.com/en/quote/INCY.US.md) - [OCC.US](https://longbridge.com/en/quote/OCC.US.md) - [WINT.US](https://longbridge.com/en/quote/WINT.US.md) - [POAS.US](https://longbridge.com/en/quote/POAS.US.md) - [APLM.US](https://longbridge.com/en/quote/APLM.US.md) - [FNMA.US](https://longbridge.com/en/quote/FNMA.US.md) ## Related News & Research - [Incyte President, Global Head of R&D Pablo J. Cagnoni sells 10,803 shares for $1.3 million](https://longbridge.com/en/news/295969312.md) - [55,370 Shares in Incyte Corporation $INCY Bought by Summit Global Investments](https://longbridge.com/en/news/295999395.md) - [Fannie Mae (OTCMKTS:FNMA) Receives Average Recommendation of "Hold" from Analysts](https://longbridge.com/en/news/295901318.md) - [Fannie Mae Announces Sale of Non-Performing Loans | FNMA Stock News](https://longbridge.com/en/news/296367903.md) - [Incyte (INCY), What Is Behind The Latest Attention?](https://longbridge.com/en/news/295686533.md)